Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-24

Clinical Trial Update: Persona Ti-Nidium Post-Market Clinical Follow-up [NA]

View source ↗

Summary

Zimmer Biomet's Persona Ti-Nidium post-market follow-up trial is active but not recruiting, focusing on knee-related conditions such as osteoarthritis and relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Persona Ti-Nidium

Snippet

Sponsor: Zimmer Biomet | Conditions: Knee Pain Chronic, Osteoarthritis | NA | Status: ACTIVE_NOT_RECRUITING